Laboratory Evaluation of FR10024, a New Cephalosporin Derivative
FR10024 is a broad-spectrum antibiotic. The in vitro antibacterial activity of FR10024 against clinical isolates of Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis is greater than that of any of the cephalosporins developed to date. Indole-positive Proteus, Ente...
Gespeichert in:
| Veröffentlicht in: | Antimicrob Agents Chemother |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Society for Microbiology (ASM)
1977
|
| Schlagworte: | |
| Online-Zugang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC351918/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/836014/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.11.1.51 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|